Riccardo Dalla-Favera obtained his Medical Doctor degree from University of Milan. In 1999 Dr. Dalla-Favera founded The Institute for Cancer Genetics at Columbia University, and to this day remains the Director. His area of research is cancer genetics. His research team has contributed significantly to the understanding of the pathogenesis of cell malignancies, including B Cell Lymphoma, and Chronic Lymphocytic Leukemia. His work is quoted in major textbooks of medicine and oncology as it directly impacts the diagnostics and therapeutic targeting of these diseases. His work is widely recognized by numerous National and International prizes and awards, including the 2006 William Dameshek Prize from the American Society of Hematology (ASH), the 2017 American Association for Cancer Research GHA Clowes Memorial Award, and the 2017 Léopold Griffuel Award in Basic Research from the Association pur la Reserche sur le Cancer (ARC), France. He is an elected member of the U.S. National Academy of Medicine and the U.S. National Academy of Sciences.